Marathon Pharmaceuticals LLC has decided to hold the launch of its newly approved Duchenne muscular dystrophy treatment Emflaza before it even started.
Company CEO Jeffrey Aronin wrote on the CureDuchenne blog Feb. 13 that after hearing concerns from patients about...



